Letter to the Editor: Stem Cell Politics
By Richard Hayes,
New York Times
| 05. 01. 2006
To the Editor:
Re "Democrats Hope to Divide G.O.P. Over Stem Cells" (news article, April 24):
I'm a lifelong Democrat, pro-choice on abortion and in favor of stem cell research. But over-the-top promotion of this research is a mistake that could come back to bite us, and its use as a wedge issue is ill advised.
Stem cells may still prove to be a therapeutic dry hole. If successfully developed, stem cell therapies are likely to be prohibitively expensive.
Stem cell research puts women who donate eggs at significant medical risk, and could foster trafficking in eggs from poor women in developing countries.
The same stem cell technologies that might have beneficial medical applications could be used by rogue scientists intent on creating human clones and genetically modified children.
Stem cell research should be allowed, but it should proceed cautiously, under tight federal oversight.
Richard Hayes
Executive Director
Center for Genetics and Society
Oakland, Calif., April 24, 2006
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
By Shoumita Dasgupta, STAT | 10.03.2025
President Trump and health secretary Robert F. Kennedy Jr. have characterized the rise in autism diagnoses in recent years as an epidemic requiring emergency intervention.
This approach is factually wrong: The broadening definition of autism and the improvement in diagnosis...
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
